Adam Taich's most recent trade in 10x Genomics Inc - Ordinary Shares - Class A was a trade of 201,704 Class A Common Stock done . Disclosure was reported to the exchange on Oct. 23, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
10x Genomics Inc - Ordinar... | Adam S. Taich | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Oct 2024 | 201,704 | 201,704 (0%) | 0% | 0 | Class A Common Stock | |
10x Genomics Inc - Ordinar... | Adam S. Taich | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Oct 2024 | 133,928 | 335,632 (1%) | 0% | 0 | Class A Common Stock | |
SomaLogic Inc - Ordinary S... | Adam Taich | Interim CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 855,000 | 855,000 | - | - | Employee Stock Option (Right to Buy) | |
SomaLogic Inc - Ordinary S... | Adam Taich | Interim CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 592,000 | 592,000 | - | - | Restricted Stock Unit (RSU) |